• Live
    • Audio Only
  • google plus
  • facebook
  • twitter
  • Eulogio Pimentel Vasquez, director of the Center for Genetic Engineering and Biotechnology (CIGB), together with the president of BioCubaFarma, Dr. Eduardo Martinez Diaz, participate in a press conference in Havana, Cuba. March 13, 2020.

    Eulogio Pimentel Vasquez, director of the Center for Genetic Engineering and Biotechnology (CIGB), together with the president of BioCubaFarma, Dr. Eduardo Martinez Diaz, participate in a press conference in Havana, Cuba. March 13, 2020. | Photo: EFE/Ernesto Mastrascusa

Published 18 September 2020
Opinion

The Cuban state enterprise, a leader in the nation's fight agaist COVID-19, is currently in conversations with Ukraine's Heart Institute to extend collaboration in the field of cardiology.

The business group for Cuba's biotechnology and pharmaceutical industries, BioCubaFarma, has signed various cooperation agreements since May with Ukrainian scientific entities to strengthen relations between the two countries in science, education, and trade.

According to a press release Friday from the official web site of Cuba's Foreign Relations Ministry, the Cuban state enterprise, a leader in the island's struggle against COVID-19, is currently in conversations with Ukraine's Heart Institute to broaden ties in the cardiological field. 

RELATED:

Cuba and the U.K. Start a Joint Venture to Develop Medicines

This month, BioCubaFarma signed a memorandum of understanding with the V.P. Komisarenko Institute of Endocrinology and Metabolism of Ukraine's Academy of Medical Sciences about the possible use of HEBERPROT-P, a leading medication produced by Cuba's biotechnology sector to treat diabetic foot ulcers.

Similarly, BioCubaFarma signed another two memoranda of understanding with Ukrainian scientific and medical organizations to confront the pandemic provoked by the SARS-Cov-2 virus. 

BioCubaFarma builds relationships with Ukraine's scientific institutions #CubaIsHealth #CubaSaves
 
The press release adds that oncology is another medical field where future collaborations can also be expected; the R.E. Kavetsky Institute for Experimental Pathology, Oncology, and Radiobiology of Ukraine's National Academy of Sciences, for example, signed an agreement with BioCubaFarma last May 2019.
 
The signing of these various agreements is the result of previous meetings between both parties, such as the first Medical-Pharmaceutical Forum that took place in Kiev in 2018, organized by both the Chamber of Commerce and Industry of Ukraine and the Cuban Chamber of Commerce. 
Comment
0
Comments
Post with no comments.